A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Conditions
Symptomatic Genetic Dilated Cardiomyopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Cedars Sinai, Los Angeles, California, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135University of California, San Diego (UCSD) - Medical Center, San Diego, California, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135UCSF, San Francisco, California, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Louisiana State University (LSU) Health Sciences Center, New Orleans, Louisiana, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Henry Ford Health System, Detroit, Michigan, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Washington University in St. Louis, St Louis, Missouri, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Columbia University Medical Center/ New York Presbyterian Hospital, New York, New York, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Aarhus University Hospital, Aarhus, Denmark
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Rigshospitalet, Copenhagen, Denmark
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Odense University Hospital - Odense, Odense, Denmark
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135AP-HP Hopital Pitie-Salpetriere, Paris, France
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Semmelweis Egyetem - Varosmajori Sziv es Ergyogyaszati Klinika, Budapest, Hungary
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Hungary
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Istituto Clinico Humanitas, Rozzano, Italy
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Azienda sanitaria universitaria Giuliano Isontina (ASU GI) - Ospedale di Cattinara, Trieste, Italy
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Lodz, Poland
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario Vall d'Hebron, Horta-Guinardó, Barcelona, Spain
Contact: Study coordinator (Kardigan Clinical Trials Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario de A Coruña, A Coruña, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitari de Bellvitge, Barcelona, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario Virgen de la Victoria, Málaga, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario Son Llatzer, Palma de Mallorca, Spain
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hospital Universitario Virgen del Rocio, Seville, Spain
Contact: Study coordinator (Kardigan Clinical Trials Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Sodersjukhuset AB, Stockholm, Sweden
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135St. Bartholomew's Hospital, London, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135St George's Hospital, London, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Royal Brompton Hospital, London, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Hammersmith Hospital, Imperial College of London, London, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135Cardiovascular Clinical Research Facility (CCRF), Oxford, United Kingdom
Contact: Study coordinator (Kardigan Clinical Trial Team) · clinicaltrials@kardigan.bio · 1-877-310-5135